Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Larger Is The Nucleic Acid Based Gene Therapy Market Expected To Become By 2029 Compared With Its 2025 Level?
The market focused on gene therapy utilizing nucleic acids has experienced significant expansion lately; its valuation is projected to advance from $0.81 billion in 2024 to reach $0.88 billion by the subsequent year, exhibiting a compound annual growth rate of 8.4%. This upward trajectory during the past period stems from several key factors including an increasing comprehension of human genetic makeup, a rising need for individualized medical treatments, an augmenting portfolio of forthcoming gene therapy solutions, greater governmental backing for gene therapy methods, and ongoing work in treating genetic ailments and various cancers.
Anticipation surrounds the nucleic acid based gene therapy sector, projecting substantial expansion in the impending years, with its market valuation projected to ascend to $1.3 billion by 2029, reflecting a consistent annual growth trajectory of 10.3%. This upward momentum throughout the predicted timeframe stems from several key factors, notably the broadening range of conditions being targeted, augmented financial support, heightened patient awareness and advocacy efforts, surging capital allocation toward gene therapy research and development endeavors, the widening applicability of gene therapy modalities, and a focus on addressing rare medical conditions. Key developments shaping the outlook for this period encompass innovations in ex vivo gene editing techniques, progress made in in vivo gene modification methods, the adoption of combination treatment approaches, the refinement of targeted delivery mechanisms, gene editing specifically applied to heretofore untreatable rare diseases, and the increased utilization of non-viral vectors.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2820&type=smp
What Are The Emerging Market Drivers Creating New Opportunities In The Nucleic Acid Based Gene Therapy Industry?
Anticipated growth in demand for nucleic acid-based gene therapy is forecasted to be propelled by increased financial backing from both governmental bodies and private enterprises. These nucleic acid therapeutics function as mimics of the natural acids or proteins that govern genetic expression. Conventional treatment modalities unfortunately lack curative options for conditions like cystic fibrosis, hemophilia, sickle cell anemia, thalassemia, and diabetes. The foundation of these therapeutic categories rests upon genetic profiling along with pinpointing molecular targets. Given that nucleic acid medications address the underlying genetic causes of illnesses, offering a permanent resolution, they possess significant prospective value for managing these ailments. Furthermore, escalating financial commitments from governmental agencies and market participants involved in gene therapy are set to boost the overall demand for the nucleic acid-based gene therapy sector; as an illustration, in August 2022, the National Institute of Health (NIH) committed to an annual investment of $34 million spanning the next five years aimed at advancing HIV treatment investigations, thereby indicating that state sponsorship for gene therapies will fuel expansion within the nucleic acid-based gene therapy market.
What Are The Emerging Segments Gaining Attention In The Nucleic Acid Based Gene Therapy Market?
The nucleic acid based gene therapymarket covered in this report is segmented –
1) By Technology: Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologies
2) By Application: Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases
3) By End User: Hospitals And Clinics, Academic And Research Institutes
Subsegments:
1) By Anti-Sense And Anti-Gene: Oligonucleotide Therapeutics, Peptide Nucleic Acids (PNA), Morpholino Oligomers (MO)
2) By Short Inhibitory Sequences (siRNA): Synthetic siRNA, Encapsulation/Delivery Systems for siRNA, Target-specific siRNA Therapies
3) By Gene Transfer Therapy: Viral Vectors (Adenovirus, Lentivirus, Retrovirus, AAV), Non-Viral Vectors (Liposomes, Electroporation, Gene Gun)
4) By Nucleoside Analogs: Purine Analogs, Pyrimidine Analogs
5) By Ribozymes: Trans-Splicing Ribozymes, Hammerhead Ribozymes
6) By Aptamers: RNA Aptamers, DNA Aptamers, Small Molecule Binding Aptamers
7) By Other Technologies: CRISPR-based Gene Editing, Zinc Finger Nucleases (ZFN), Transcription Activator-Like Effector Nucleases (TALENs)
Which Industry Leaders Are Driving Innovation Across The Nucleic Acid Based Gene Therapy Market?
Major companies operating in the nucleic acid based gene therapy market include Celsion Corporation, Wave Life Sciences, Imugene Ltd., Caperna LLC, Phylogica Limited, Protagonist Therapeutics Inc., Benitec Biopharma Ltd., EGEN, BioMedica, Transgene SA, Copernicus Therapeutics Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Alnylam Pharmaceuticals Inc., Amgen Inc., Beam Therapeutics Inc., BioNTech SE, Bluebird Bio Inc., CRISPR Therapeutics AG, Editas Medicine Inc., Genevant Sciences Inc., Homology Medicines Inc., Intellia Therapeutics Inc., Ionis Pharmaceuticals Inc., MaxCyte Inc., Moderna Inc., Novartis International AG, Orchard Therapeutics plc, Precision BioSciences Inc., REGENXBIO Inc.
Download The Full Report For Exclusive Market Findings:
How Does The Nucleic Acid Based Gene Therapy Market Perform Across Key Geographic Regions?
North America was the largest region in the nucleic acid-based gene therapy market in 2024. Western Europe was the second-largest region in the nucleic acid-based gene therapy market report. The regions covered in the nucleic acid based gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Request A Customized Version Of The Nucleic Acid Based Gene Therapy Market Report:
https://www.thebusinessresearchcompany.com/customise?id=2820&type=smp
Browse Through More Reports Similar to the Global Nucleic Acid Based Gene Therapy Market 2025, By The Business Research Company
Genes Therapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report
Gene Editing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report
Next Generation Sequencing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model